methyl amino(3-hydroxyphenyl)acetate | 130697-96-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: methyl amino(3-hydroxyphenyl)acetate
• 英文别名: DL-2-Amino-2(3'-hydroxyphenyl)essigsaeure-methylester；Methyl 2-amino-2-(3-hydroxyphenyl)acetate
• CAS: 130697-96-0
• 化学式: C₉H₁₁NO₃
• mdl: MFCD12151729
• 分子量: 181.191
• InChiKey: DWPGVIHUPCKHJI-UHFFFAOYSA-N

物化性质

• 熔点：
  175-177 °C(Solv: ethanol (64-17-5))
• 沸点：
  316.2±27.0 °C(Predicted)
• 密度：
  1.248±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  72.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl amino(3-hydroxyphenyl)acetate 在 palladium on activated charcoal 咪唑 、 palladium diacetate 、 sodium hydroxide 、 锂硼氢 、 草酰氯 、 1,3-双(二苯基膦)丙烷 、 四丁基氟化铵 、 氢气 、 碳酸氢钠 、 potassium carbonate 、 三乙胺 、 silver(l) oxide 作用下， 以 四氢呋喃 、 吡啶 、 甲醇 、 乙醚 、 二甲基亚砜 、 N,N-二甲基甲酰胺 、 丙酮 、 甲苯 为溶剂， 反应 76.0h， 生成 Octanoic acid {2-benzyloxy-1-[3-(2-diazo-acetyl)-phenyl]-ethyl}-amide
  参考文献：
  名称：

  Highly potent inhibitors of TNF-α production. Part I

  摘要：

  Discovery of new chemical leads of inhibitors for TNF-alpha production starting from the chemical modification of I is reported. Further biological studies of 1 to disclose the site of its action strongly suggested that 1 inhibits LPS-induced TNF-alpha expression in the liver and spleen of mice. Structure-activity relationships (SARs) are also discussed and full details including the chemistry are reported. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(02)00381-4
• 作为产物：
  描述：

  甲醇 、 (Rs)-3-羟基苯甘氨酸 在 氯化亚砜 作用下， 反应 2.0h， 生成 methyl amino(3-hydroxyphenyl)acetate
  参考文献：
  名称：

  [EN] GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
  [FR] ANTAGONISTES DES RÉCEPTEURS DE L'HORMONE DE LIBÉRATION DES GONADOTROPHINES, LEUR PROCÉDÉ DE PRÉPARATION ET COMPOSITION PHARMACEUTIQUE LES COMPRENANT

  摘要：

  本发明提供了促性腺激素释放激素受体拮抗剂及包括其的药物组合物，可用于预防或治疗与性激素相关的疾病，如子宫内膜异位症、闭经、月经不调、子宫肌瘤、子宫肌瘤、多囊卵巢综合征、红斑狼疮、多毛症、性早熟、身材矮小、痤疮、脱发、性腺类固醇依赖性肿瘤、促性腺激素产生性垂体腺瘤、睡眠呼吸暂停、肠易激综合征、经前综合征、良性前列腺增生、避孕和不孕症，以及阿尔茨海默病。

  公开号：

  WO2013129879A1

文献信息

• Highly potent inhibitors of tnf-α production. Part II: metabolic stabilization of a newly found chemical lead and conformational analysis of an active diastereoisomer
  作者：Toshiaki Matsui、Takashi Kondo、Yoshitaka Nishita、Satoshi Itadani、Hiroshi Tsuruta、Setsuko Fujita、Nagashige Omawari、Masaru Sakai、Shuichi Nakazawa、Akihito Ogata、Hideaki Mori、Wataru Kamoshima、Kouichiro Terai、Hiroyuki Ohno、Takaaki Obata、Hisao Nakai、Masaaki Toda

  DOI：10.1016/s0968-0896(02)00380-2

  日期：2002.12

  Design and synthesis of metabolically stabilized inhibitors of TNF-alpha production, which could be new drug candidates, are reported. Conformational analysis of an active diastereoisomer was performed based on biological evaluations of the conformationally fixed indane derivatives 17 and 18. Structure-activity relationships (SARs) based on biological evaluations of the optically active derivatives

  据报道可能是新药候选者的代谢稳定的TNF-α抑制剂的设计和合成。基于构象固定的茚满衍生物17和18的生物学评价，进行了活性非对映异构体的构象分析。还讨论了基于光学活性衍生物的生物学评价的构效关系（SAR）。报告了包括化学在内的全部详细信息。
• GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
  申请人：SK CHEMICALS CO., LTD.

  公开号：US20150166558A1

  公开（公告）日：2015-06-18

  Disclosed are a gonadotropin releasing hormone receptor antagonist and a pharmaceutical composition including the same, which can be useful in preventing or treating a sex hormone-related disease such as endometriosis, amenorrhea, irregular menstruation, uterine myoma, uterine fibroids, polycystic ovarian disease, lupus erythematous, hypertrichosis, precocious puberty, short stature, acne, alopecia, gonadal steroid-dependent neoplasms, gonadotropin-producing pituitary adenoma, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hyperplasia, contraception, and infertility, as well as Alzheimer disease.

  揭示了一种促性腺激素释放激素受体拮抗剂和包括该拮抗剂的药物组合物，可用于预防或治疗与性激素相关的疾病，如子宫内膜异位症、闭经、月经不调、子宫肌瘤、子宫纤维瘤、多囊卵巢综合征、红斑狼疮、多毛症、性早熟、身材矮小、痤疮、脱发、性腺类固醇依赖性肿瘤、促性腺激素产生垂体腺瘤、睡眠呼吸暂停、肠易激综合征、经前综合征、良性前列腺增生、避孕和不孕症，以及阿尔茨海默病。
• Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)
  作者：Frank Lovering、Steve Kirincich、Weiheng Wang、Kerry Combs、Lynn Resnick、Joan E. Sabalski、John Butera、Julie Liu、Kevin Parris、J.B. Telliez

  DOI：10.1016/j.bmc.2009.03.041

  日期：2009.5

  A novel series of inhibitors for mitogen activated protein kinase-activated protein kinase 2 (MK-2) are reported. These squarate based inhibitors were identified via a high-throughput screen. An MK2 co-structure with the starting ligand was obtained and a structure based approach was followed to optimize potency and selectivity.
• US9481684B2
  申请人：——

  公开号：US9481684B2

  公开（公告）日：2016-11-01
• [EN] SQUARATE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE LA SQUARATE KINASE
  申请人：WYETH CORP

  公开号：WO2009012375A2

  公开（公告）日：2009-01-22

  The present application provides compounds of Formula (I): and pharmaceutically acceptable salts thereof and pharmaceutical compositions thereof, wherein Het, R4, R9, and R10 are defined herein. Compounds of formula (I) are useful as inhibitors of MAP kinase activated protein kinase 2 (MK2).